Transparency Market Research (TMR) has published a new report titled ‘Intracranial Stents Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global intracranial stents market was valued at US$ 298.7 Mn in 2017.

It is projected to expand at a CAGR of 10.4% from 2018 to 2026.

Aging population and longer life-expectancy, increased awareness, and acceptance of advanced devices are key factors that are likely to drive the intracranial stents market from 2018 to 2026.Intracranial stents is a considerably less invasive technique, as compared to the conventional open surgery, for the management of vascular malformation.

Hence, there are fewer complications and the hospital stay is relatively brief.

Blood loss is lesser than traditional surgical treatment, and there is no obvious surgical incision.

Intracranial stents is an effective and safe minimally-invasive alternative to surgery.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=46416The report offers detailed segmentation of the global intracranial stents market based on product type, disease indication, end-user, and region.

Transparency Market Research (TMR) has published a new report titled, “Joint Replacement Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.

High prevalence of osteoarthritis, growth in the medical devices industry in emerging economies in regions such as Asia Pacific, and launch of technological advanced products such as customized knee implants are projected to augment the global market between 2018 and 2026.High Prevalence of Osteoarthritis to Propel MarketOsteoarthritis is a common disorder that affects the adult and geriatric population across the globe.

This condition can be treated through joint replacement surgeries using orthopedic knee and hip implants.

According to the World Health Organization (WHO), 130 million people are likely to suffer from osteoarthritis worldwide, out of which 40 million people are projected to be severely disabled by the disease by 2050.Request a PDF Sample -https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=45072Rapidly Growth in Medical Devices Industry to Create Opportunities in MarketDemand for medical devices used for surgical procedures and diagnosis of diseases is high.

Use of robotics and artificial intelligence in the health care setting has improved health care delivery and increased the demand for medical devices.

Key players operating in the orthopedic industry are extensively engaged in research & development activities to develop new and upgrade existing devices for better application in joint replacement surgeries.

The U.S. pet medication market is majorly driven by changing socio economic and cultural factors that have led to domestic pets being regarded as member of family.

This in turn increases pet owner’s spending from innovative and specialized premium product and grooming expenses to medication drugs.Moreover, with the increasing trend of nuclear family and increasing disposable income the ownership of pets among middle class family is growing exponentially.

The increasing number of pet owners and their growing concern towards pets, in turn is also expected to boost the U.S. pet medication market.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=11102However, the rising incident of pet allergy and increasing prices of pet medications products acts as restraining factor for the growth of pet care market.

The canine care medication segment held the largest share in the U.S. pet medication market and is anticipated to experience a constant growth during the focus period.Request for TOC @https://www.transparencymarketresearch.com/sample/sample.php?flag=T_id=11102The rise in the number of canine owners and high spending on canine care, coupled with high adoption rate of canines for companionship and for security purpose is expected to further boost the demand for medications for canine care.

The canine care medication market is followed by feline care medication market.On the basis of type of disease, the market can be segmented into parasite prevention and control (flea, tick, heartworm, etc.

The parasite prevention and control segment held the largest share during the forecast period.

This annual rate is striking especially as nearly 45% Americans suffer from at least one of these chronic illnesses.

These illnesses can require long hospital stays and apart from challenge on the healthcare front, also increase liabilities and waste management inefficiencies considerably for hospitals.Additionally, the rising elderly population is expected to make challenges worse in the near future, as more than 50% of aging population lives with three or four illnesses simultaneously.

According to a 2019 study, the United States spends over 18% of its gross domestic product on healthcare.

Moreover, out of this nearly 30% goes to waste, or about $760 to $935 billion.Additionally, the study also showed that measures to reduce waste resulted in nearly $300 billion savings.

According to research, there is a potential to reduce 25% of the costs in healthcare with simple measures like reduction in waste usage among several other policy implementations.Stringent Legislations Promise New OpportunitiesAdditionally, incidents of wastage on public display can threaten severe legislations.

Additionally, the cost rises at rapid rate, nearly 10 or 12% each year with major concerns about medical waste.Buy Medical Waste Management Market Report -https://www.transparencymarketresearch.com/checkout.php?rep_id=2268=SMoreover, recently littering of medical waste on California beaches came to light.

The global diabetic ulcers treatment market was valued at approximately US$ 7.3 Bn in 2017.

It is projected to expand at a compound annual growth rate (CAGR) of more than 7.0% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled ‘Diabetic Ulcers Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ Expansion of the health care industry, government initiatives, increase in health care expenditure, rise in product approvals, and increase in the patient population are projected to augment the global market from 2018 to 2026.North America and Western Europe are likely to account for a dominant share of the global diabetic ulcers treatment market, as key players introduce their new diabetic ulcers treatment in these developed regions.

Development of health care infrastructure and high medical expenditure by governments in emerging economies, such as China and India, are likely to boost the diabetic ulcers treatment market in Asia Pacific at a CAGR of around 8.3% from 2018 to 2026.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=57765Rise in prevalence of diabetic foot ulcers across the globe to propel marketChronic wounds have created a significant socioeconomic impact.

Lifetime risk of developing diabetic foot ulcer among the diabetic population is 25%.

Better access to advanced wound care and increase in awareness about cost-effectiveness of advanced wound care therapies have led to a shift toward these solutions and products.Request for Custom Research -https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=57765Adoption of solutions and products such as negative pressure wound therapy (NPWT) and biologics, such as growth factors, skin grafts, and substitutes, has increased among health care providers.

Expanding economies in Asia Pacific offer significant opportunities to diabetic ulcers treatment manufacturers.

The global surgery tables market is projected to experience high demand for general surgery tables and imaging tables during the forecast period 2018–2026, states a research report by Transparency Market Research (TMR).

Thus, this study works as a guide that delivers all data and analysis on the market for surgery tables.Over the period of past few years, the number of surgical procedures is increased across major parts of the globe.

This scenario is creating high demand opportunities for players in the global surgery tables market during the forecast period from 2018 to 2026.

At present, powered and non-powered are the two types of surgical tables available in the market.

Of them, the demand for powered surgical tables is projected to increase in the upcoming years as these products offer more convenience than non-powered ones.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=50400Increased Demand for Sophisticated Surgical Tables for Hybrid Operating Rooms Creates Prominent Avenues for Market GrowthSeveral developed and developing nations across the globe are growing focus on strengthening their healthcare infrastructure and thus investing heavily in the health industry.

This aside, the market is expected to gain the advantage of growing trend of using sophisticated surgical tables across hybrid operating rooms of many hospitals.Players Focus on Expanding Businesses through Regional Expansion and New Product LaunchesSTERIS plc, Stryker, Mizuho OSI, Hill-Rom Services, Inc., Surgical Tables Inc., Getinge AB, BARRFAB, Merivaara Corp, and AMTAI Medical Equipment, Inc. are some of the key players working in the global surgery tables market.

Global Personalized Cancer Genome Sequencing Market: OverviewCancer genome sequencing refers to the specialized field of genetic engineering focusing on the identification of genetic sequence in cancer cells.

Across the globe, the vast rise in prevalence of a variety of cancers has led to a significant rise in research activities aimed at the formulation of effective and accurate diagnostic and treatment methods.Read Report Overview -https://www.transparencymarketresearch.com/personalized-cancer-genome-sequencing-market.htmlOver the past few years, intense research and technological developments in genetic engineering have made the personalized cancer genome sequencing technology a reliable technique for the treatment of several kinds of cancers.

This report on the global personalized cancer genome sequencing market presents a detailed overview of the market with the help of in-depth quantitative and qualitative details and verifiable forecast about market’s future growth prospects.Global Personalized Cancer Genome Sequencing Market: Trends and OpportunitiesThe vast rise in prevalence of cancer across the glove, rising awareness regarding the available treatment methods in the market, and a rising openness towards the adoption of promising futuristic treatment methods are the key factor driving the global personalized cancer genome sequencing market.

The market is also driven due to the vast developments observed in gene sequencing techniques and the high accuracy in results.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=12248Being a relatively new method of cancer treatment, personalized cancer genome sequencing method is presently under clinical trials in several countries.

In some countries across regions such as North America and Europe, these methods are practiced but are dealt through stringent regulatory control and taxing approval procedures from regulatory bodies.

In the United States alone, the personalized cancer genome sequencing market is regulated by bodies such as Centers for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), and the U.S. FDA.Global Personalized Cancer Genome Sequencing Market: Regional OutlookFrom a geographical perspective, the personalized cancer genome sequencing market has been examined in the report for regional markets such as Asia-Pacific, Europe, North America, and Middle East and Africa.

Retinal Disorders Treatment Market: IntroductionAccording to the report, the global retinal disorders treatment market was valued at US$ 9.18 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

Macular degeneration is of two types: wet age-related macular degeneration and dry age-related macular degeneration.

Diabetic retinopathy is one of the common diabetic eye disorders characterized by damaged blood vessels in the retina.

The U.S. dominated the global retinal disorders treatment market in 2019, and the trend is anticipated to continue during the forecast period.

Moreover, rise in prevalence of various types of retinal disorder leads to increase in demand for treatment.China is likely to be a highly lucrative market for retinal disorders treatment during the forecast period.

Increase in R activities, rise in the number of patients suffering from diseases, and rapid expansion of healthcare and biopharmaceutical industries in developed and developing countries are projected to boost advancements in therapies in the AMD treatment market during the forecast period.

Transparency Market Research (TMR) has published a new report titled ‘Operating room equipment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global operating room equipment market was valued at US$ 29,912.3 Mn in 2017.

It is projected to expand at a CAGR of 6.4% from 2018 to 2026.

Aging population and longer life-expectancy, increased awareness, and acceptance of advanced devices are likely to drive the operating room equipment market from 2018 to 2026.An operating room, also known as operation theatre, is a facility within a hospital or nursing home where surgical procedures are performed in order to treat different physiological conditions in a sterile environment.

An operating room encompasses equipment such as movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes.Request a PDF Sample -https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=1674Significant advantages associated with operating room equipment and financial incentives by governments of various countries are major factors driving the operating room equipment market globally.

Benefits of proper operating room equipment encompasses accurate and up-to-date patient handling, enhanced patient safety, and time and long-term cost savings.

Advancements in patient monitoring systems include heart monitors, breath monitors, body temperature monitors, hematology monitors, multi-sign monitors, fetal and maternal monitors, oximeter, and brain monitors.

Infectious diseases are rising at a rapid pace over the years.

Thus, based on these factors, the blood gas and electrolyte analyzer market is expected to observe steady growth during the forecast period of 2017-2023.Read Report Overview -https://www.transparencymarketresearch.com/blood-gas-electrolyte-analyzers.htmlBlood samples play a crucial role in diagnosing both contagious and non-contagious diseases.

Thus, owing to these capabilities, the blood gas and electrolyte analyzer market is expected to experience a stable growth trajectory based on the growing demand.The advent of innovative technologies across the healthcare sector has led to extensive advancements in the blood gas and electrolyte analyzer market.

The players are involved in research and development activities for deriving new formulations and upgrades in the analyzers, which helps in increasing the revenues.

The activities help in strengthening the influence of the players, eventually increasing the growth rate.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1780Factors like rising geriatric population and an unhealthy lifestyle have resulted in an increase in the prevalence of chronic diseases like diabetes, asthma, kidney failure, heart failure, and others.

This aspect will propel the combination blood gas and electrolyte analyzers segment to expand at a CAGR of 10.4% during the forecast period of 2017-2023.Request for Analysis of COVID19 Impact on Blood Gas and Electrolyte Analyzer Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1780North America to Emerge as Dominant RegionIn the context of revenue and volume, North America’s blood gas and electrolyte analyzer market is expected to witness a dominating stance.

Global Neurovascular Stent Retriever Technology Market: SnapshotIschemic stroke is currently one of the leading causes of death or disability within the western world.

One of the more effective treatments currently is the use of tissue plasminogen activators in systemic thrombolysis.

A large number of clinical tests and results are falling in favor of the more innovative designs in the global neurovascular stent retriever technology market and the ability of these technologies to swiftly and efficiently restore flow.

The report segments the global neurovascular stent retriever technology market on the basis of technology, geography, and product.

However, a dearth of skilled neurosurgeons, coupled with the high level of complexity involved with neurological surgeries, is hampering the growth of the market.Request for TOC @https://www.transparencymarketresearch.com/sample/sample.php?flag=T_id=11195The global neurovascular stent retriever technology market is segmented on the basis of product into snares, suction and aspiration devices, flow diversion devices, embolic coils, clot retrievers, microcatheters, cerebral balloon angioplasty and stenting systems, support devices, embolic protection systems, and carotid artery stents.By geography, North America leads in the global neurovascular stent retriever technology market owing to the easy accessibility to advanced healthcare options in the region.

Significant investments in research and development activities are also helping the market’s growth.

Antiviral Combination Therapies Market: IntroductionAccording to the report, the global antiviral combination therapies market was valued at US$ 40.4 Bn in 2019 and is projected to expand at a high CAGR from 2020 to 2030.

Antiviral combination therapies are drugs developed using a combination of two or more drugs for the treatment of various viral diseases, including chronic hepatitis B, hepatitis C, and HIV.

Combination antiretroviral therapy aids in stopping the virus from making multiple copies of itself in the body.The growth of the global antiviral combination therapies market can be attributed to the increase in investment in research & development for the development of combination medications that aid in fighting antiviral resistance, surge in demand for antiviral combinations for the treatment of HIV, rise in prevalence of viral diseases, and increase in focus on the development of vaccines for fighting the pandemic of COVID-19.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=76997North America dominated the global antiviral combination therapies market in terms of revenue in 2019 and the trend is anticipated to continue during the forecast period.

Furthermore, patent protection of the drugs is likely to contribute to the growth of the market during the forecast period.Product Approvals Received by Companies Boost Market GrowthLeading players, such as Celltrion and Gilead, focus on enhancing their market presence through product approvals.

In September 2019, Celltrion received the U.S. FDA approval for its Temixys, a once-daily combination of two nucleoside reverse transcriptase inhibitors, for the treatment of HIV.

In March 2019, Gilead received approval for its Biktarvy (Bictegravir, Emtricitabine and Tenofovir Alafenamide) for the treatment of HIV-1 infection from the Japanese Ministry of Health, Labour and Welfare (MHLW).Request for Custom Research -https://www.transparencymarketresearch.com/sample/sample.php?flag=CR_id=76997Integrase Inhibitor/NRTI Drug Combination Dominated Global MarketIn terms of drug combination, the integrase inhibitor/NRTI segment is projected to account for a major share of the global antiviral combination therapies market during the forecast period.

The global offsite medical case management market was valued at US$ 4,063.2 Mn in 2017.

It is projected to expand at a compounded annual growth rate (CAGR) of more than 4.2% from 2018 to 2026, according to a new report published by Transparency Market Research (TMR) titled “Offsite Medical Case Management Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”.The report suggests that factors such as rise in adoption of offsite medical case management, growth in patient pool, increase in geriatric population, and surge in prevalence of chronic diseases and injuries are likely to boost the demand for offsite medical case management in the next few years.

In Asia Pacific, increase in government support and rise in awareness regarding offsite medical case management are projected to drive the growth of the market from 2018 to 2026.Rise in geriatric population worldwideImprovement in health care reforms in Japan, the U.S., China and the U.K., has enhanced access to various medical treatment services, resulting in increased life expectancy of the people in these countries.

Geriatric population is expected to increase rapidly in developed countries, such as, the U.S. and JapanAccording to the U.S. Census Bureau, in 2009, around 13% of the total population of the U.S. was older than 65 years, and is estimated to grow at a rate of 20% till 2030.

According to figures published in the United Nations’ “World Population Prospects,” the global population of those aged 100 years and above would be considerably large by 2050, followed by the 85+ and 65+ age groups.Request for Analysis of COVID-19 Impact on Offsite Medical Case Management Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=25943Growth in geriatric population is anticipated to boost the demand for health care products and services as elderly people are more prone to respiratory (tuberculosis and pneumonia), oral, orthopedic (osteoporosis), and cardiovascular diseases.

This can be attributed to the ready availability of facilities in long-term care centers, as these centers are specially designed for keeping a check on health and also for providing immediate diagnosis and treatment of diseases.Asia Pacific market to expand significantly and create high incremental opportunityBased on geography, the global offsite medical case management market has been divided into major five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regulatory affairs outsourcing is becoming more common in the healthcare business.

The use of regulatory outsourcing models is likely to be aided by a rise in geographical expansion activities by firms seeking quick approvals in local markets.

Especially with the rise in product registration, clinical trial applications, and research and development activities, the global regulatory affairs outsourcing market is likely to grow quickly.

At the same time, expenditures in regulatory information systems have risen significantly in order to keep up with the requirement to automate tasks such as publication and regulatory procedures.Some of the key players in the global regulatory affairs outsourcing market comprise Accell Clinical Research, LLC, Pharmaceutical Product Development, LLC (PPD), Accell Clinical Research, LLC, Charles River Laboratories International, Inc., WuXi AppTec, Inc., PRA Health Sciences.Request Brochure of Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=3528The report points out that the global regulatory affairs outsourcing market is expected to grow at a stable pace of 3.2% CAGR during the forecast period.Driven by Immense Growth Potential to Boost Growth of the Market in North AmericaIn terms of region, the global regulatory affairs outsourcing market is classified into the principal regions of Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

This may be linked to an increase in clinical trials as well as a rise in the number of firms attempting to penetrate markets with immense growth potential such as China and India.

Another element predicted to drive regional growth is the presence of a qualified manpower in the region at a cheaper cost than in the US.Because of the existence of two major international regulatory agencies—US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), North America and Europe are likely to be the primary regional markets for regulatory affairs outsourcing market.Request for TOC @https://www.transparencymarketresearch.com/report-toc/3528Need to Lower Medical Costs to Drive Demand in the Regulatory Affairs Outsourcing MarketEconomic and market challenges in the healthcare business keep pushing life sciences firms to look for cost-cutting opportunities across operations.

Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue.

Neurofibromatosis is usually diagnosed in childhood or early adulthood.Read Report Overview -https://www.transparencymarketresearch.com/neurofibromatosis-treatment-market.htmlThe tumors are noncancerous (benign) in most of the cases, but in some cases these tumors become cancerous (malignant) tumors.

People suffering with neurofibromatosis often experience only mild symptom and effects may range from hearing loss, learning impairment, and heart and blood vessel (cardiovascular) complications to severe disability due to nerve compression by tumors, loss of vision and severe pain.There is no specific treatment for neurofibromatosis, but treatment aims to maximize healthy growth and development and to manage complications as soon as they arise.

When neurofibromatosis causes large tumors or tumors that press on a nerve, surgery may help ease symptoms.

There are currently no drugs in the market for neurofibromatosis treatment, however ever certain drugs in the phase III of the clinical trials include Lamotrigine (Erasmus Medical Center), and Tamsulosin HCL (GL Pharm Tech Corporation).

The drugs in the phase II of the clinical trials include Cabozantinib (University of Alabama at Birmingham), RAD001 (Assistance Publique - Hôpitaux de Paris), Gleevec (Indiana University), Everolimus (Texas Neurofibromatosis Foundation) and others.Geographically, Neurofibromatosis is an orphan disease, and the prevalence rate of neurofibromatosis is low.

Transparency Market Research (TMR) has published a new report titled, Photopheresis Products Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

According to the report, the global photopheresis products market was valued at US$ 262.4 Mn in 2018 and is projected to expand at a CAGR of above 5.3% from 2019 to 2027.OverviewPhotopheresis products are mainly used to treat cutaneous T-cell lymphoma conditions.

New therapeutic indications options are boosting the growth of this market.Furthermore, photopheresis therapy is majorly used in treating the patients who are not responding to steroids therapy in transplant rejection conditions.

Photopheresis therapy is safer therapy when compared with steroids due to lack of side effects.North America dominated the global photopheresis therapy market in 2018 and the trend is anticipated to continue during the forecast period, As Governments provide reimbursement for various disease indications such as GVHD, CTL, and lung transplantations that are treated by ECP therapy.Request a PDF Sample -https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=14771Corporate entities boosting the research activities on ECP therapy to Drive Photopheresis Products MarketCorporates are actively encouraging research on photopheresis treatment by providing monetary support to researchers.In 2014, Freseinus Kabi conducted an award contest on advanced research in therapeutic apheresis and cell therapy.

The company has granted US$ 100,000 to the research team led by John Koreth, Dana Farber Cancer Institute, for his work on treating chronic GvHD condition by using photopheresis and low-dose interleukin-2 (IL-2).Closed System Segment to Capture Largest Market ShareBased on product, closed system devices has the highest revenue as compared to open systems and is expected to be dominate over the forecast period in 2019, as closed photopheresis system is the only FDA approved system to treat CTL conditions.Request for Analysis of COVID19 Impact on Photopheresis Products Market -https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=14771Graft versus host disease to dominate Market in Term of Therapeutic ApplicationBased on therapeutic area, the market has been segmented into cutaneous T-cell lymphoma, graft versus host disease, transplant rejections and autoimmune diseases.

In 2012, Medicare extended reimbursement coverage for ECP therapy to treat bronchiolitis obliterans syndrome (BOS), a chronic lung allograft transplant dysfunction in the U.S.Competitive LandscapeCompanies have developed advanced photopheresis medical devices to overcome the problems of conventional medical devices.